Home support program for bladder cancer treatment
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a home-based supportive care program for people with non-muscle-invasive bladder cancer who are receiving treatment through a tube into the bladder after surgery. The program aims to provide extra support and education to help you manage your care at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have non-muscle-invasive bladder cancer and be receiving the medication through a tube into your bladder.
- You should be able to understand and communicate clearly.
- You need to be expected to live at least 6 more months.
- You must sign a consent form and be willing to take part.
- You cannot have serious heart, blood vessel, liver, kidney, or mental health problems.
- You cannot have other types of cancer, a history of bad allergic reactions, or be unable to have bladder perfusion treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study from the University of Aarhus looks at ways to support sexual health in people who have been treated for bladder cancer. If you are a Danish-speaking adult who had bladder cancer treatment about a year ago and have noticed changes in sexual function, you may be able to join.
This trial tests a combination of chemotherapy and immunotherapy to treat large, non-invasive bladder cancer before and after surgery. It aims to avoid removing the bladder while still effectively treating the cancer.
This trial tests whether patients with early-stage bladder cancer can safely receive their usual bladder chemotherapy or immunotherapy at home instead of in the clinic. It aims to make treatment more convenient while keeping it effective.
This trial tests giving BCG immunotherapy at home instead of in the clinic, to reduce the burden of travel and hospital visits. It may help patients with non-muscle invasive bladder cancer who need BCG treatment after surgery.
This study tests a combination of bladder-sparing treatments for muscle-invasive bladder cancer, including surgery, chemotherapy, immunotherapy, and radiation, followed by maintenance immunotherapy. The goal is to see if this approach can control cancer while preserving the bladder, compared to a watch-and-wait approach.
This study is testing a way for people with early-stage bladder cancer to receive their BCG treatment at home, with extra support. It aims to see if doing treatment at home is safe and helpful for patients.
Hear when a new Non-Muscle-Invasive Bladder Cancer (NMIBC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.